Retatrutide Research Overview
Retatrutide (LY3437943) is a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors. It is one of the most-researched next-generation incretin peptides, studied for its effects on energy expenditure, glucose regulation, and body composition. This overview covers its mechanism, purity standards, and sourcing in India.
Mechanism of Action
Retatrutide acts on three receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This triple agonism distinguishes it from dual agonists like Tirzepatide (GLP-1 + GIP) and single agonists like semaglutide (GLP-1 only).
The glucagon receptor activity is particularly notable — it is associated with increased energy expenditure and fat oxidation, which is why Retatrutide is studied in metabolic and obesity research.
Purity and Quality Standards
RetraLabs supplies Retatrutide at 99.2% HPLC-verified purity. Every batch is independently tested by HPLC, and a Certificate of Analysis documents purity, batch number, and identity.
Retatrutide is supplied as a sterile, nitrogen-sealed lyophilised powder from GMP-certified manufacturers. Pricing starts at ₹3,600 for a 10mg starter vial, with multi-vial packs at lower per-vial cost.
Retatrutide vs. Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Retatrutide adds a third target — the glucagon receptor — making it a triple agonist. The additional glucagon activity is studied for its effects on energy expenditure, which is not a primary target of Tirzepatide.
Both are available from RetraLabs in India with HPLC verification and COA. Researchers choose based on their specific receptor-pathway requirements.
Frequently Asked Questions
What is Retatrutide?
Retatrutide (LY3437943) is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied in metabolic and obesity research.
Where can I buy Retatrutide in India?
RetraLabs supplies 99.2% HPLC-verified Retatrutide in India with COA, starting at ₹3,600 for 10mg. India-wide shipping with COD.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide is a triple agonist that also targets the glucagon receptor, studied for broader metabolic effects.
Research Use Only — All products mentioned in this guide are supplied strictly for in-vitro laboratory research and analytical purposes. Not intended for human consumption.
